TRPV1 receptor antagonist (AlzeCure)

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameTRPV1 receptor antagonist (AlzeCure)

Drug Alias NameVR1 antagonist - AlzeCureTRPV1 receptor antagonist - AlzeCure

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVanilloid receptor antagonists

TargetsTransient receptor potential cation channel subfamily V member 1

Therapy Area/IndicationsNeuralgia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeuralgia

Inactive IndicationsN/A

ATC CodeN/A